Cover Image

Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy

In-vivo dosimetry (IVD) is a patient specific measure of quality control and safety during radiotherapy. With regard to current reporting thresholds for significant occurrences in radiotherapy defined by German regulatory authorities, the present study examines the clinical feasibility of superficia...

Full description

Saved in:
Bibliographic Details
Main Authors: Höfel, Sebastian (Author) , Gandalini, Matteo (Author) , Fix, Michael K. (Author) , Drescher, Malte (Author) , Zwicker, Felix (Author)
Format: Article (Journal)
Language:English
Published: 30 October 2021
In: Radiation oncology
Year: 2021, Volume: 16, Pages: 1-13
ISSN:1748-717X
DOI:10.1186/s13014-021-01938-8
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13014-021-01938-8
Get full text
Author Notes:Sebastian Höfel, Matteo Gandalini, Michael K. Fix, Malte Drescher and Felix Zwicker
Description
Summary:In-vivo dosimetry (IVD) is a patient specific measure of quality control and safety during radiotherapy. With regard to current reporting thresholds for significant occurrences in radiotherapy defined by German regulatory authorities, the present study examines the clinical feasibility of superficial electron paramagnetic resonance (EPR) IVD of cumulative total doses applied to breast cancer patients treated with helical intensity-modulated radiotherapy (tomotherapy).
Item Description:Gesehen am 04.02.2022
Physical Description:Online Resource
ISSN:1748-717X
DOI:10.1186/s13014-021-01938-8

Similar Items